BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29761250)

  • 21. Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.
    Agresta L; Salloum R; Hummel TR; Ratner N; Mangano FT; Fuller C; McMasters RL; Pater L; Jones BV; Szabo S; Pressey JG
    Pediatr Blood Cancer; 2019 Feb; 66(2):e27520. PubMed ID: 30408304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SMARCB1/INI1 Loss in Epithelioid Schwannoma: A Clinicopathologic and Immunohistochemical Study of 65 Cases.
    Jo VY; Fletcher CDM
    Am J Surg Pathol; 2017 Aug; 41(8):1013-1022. PubMed ID: 28368924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary epithelioid sarcoma of the kidney and adrenal gland: report of 2 cases with immunohistochemical and molecular cytogenetic studies.
    Alikhan MB; Pease G; Watkin W; Grogan R; Krausz T; Antic T
    Hum Pathol; 2017 Mar; 61():158-163. PubMed ID: 27769872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2.
    Sarkar S; Throckmorton W; Bingham R; Msaouel P; Genovese G; Slopis J; Rao P; Sadighi Z; Herzog CE
    Curr Oncol; 2023 Mar; 30(3):3355-3365. PubMed ID: 36975468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
    Sestini R; Bacci C; Provenzano A; Genuardi M; Papi L
    Hum Mutat; 2008 Feb; 29(2):227-31. PubMed ID: 18072270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.
    Castellanos E; Bielsa I; Carrato C; Rosas I; Solanes A; Hostalot C; Amilibia E; Prades J; Roca-Ribas F; Lázaro C; Blanco I; Serra E;
    BMC Med Genomics; 2015 Jan; 8():2. PubMed ID: 25739810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-grade malignant peripheral nerve sheath tumour presenting as retroperitoneal spindle cell neoplasm.
    Karn M; Mahato BK; Ojha L; Thapa Y; Bhatta S; Sharma S; Chapagain S; Ranabhat S; Neupane BR; Shrestha DM
    J Int Med Res; 2024 May; 52(5):3000605241255504. PubMed ID: 38759217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas.
    Sápi Z; Papp G; Szendrői M; Pápai Z; Plótár V; Krausz T; Fletcher CD
    Genes Chromosomes Cancer; 2016 Oct; 55(10):786-802. PubMed ID: 27223121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent malignant peripheral nerve sheath tumour in a patient with neurofibromatosis Type 1: a case report.
    Dimou J; Jithoo R; Pitcher M; White G
    J Clin Neurosci; 2009 Sep; 16(9):1221-3. PubMed ID: 19539475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJ.
    Brenca M; Rossi S; Lorenzetto E; Piccinin E; Piccinin S; Rossi FM; Giuliano A; Dei Tos AP; Maestro R; Modena P
    Mol Cancer Ther; 2013 Jun; 12(6):1060-72. PubMed ID: 23576573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple primary malignancies associated with a germline SMARCB1 pathogenic variant.
    Eelloo JA; Smith MJ; Bowers NL; Ealing J; Hulse P; Wylie JP; Shenjere P; Clarke NW; Soh C; Whitehouse RW; Jones M; Duff C; Freemont A; Gareth Evans D
    Fam Cancer; 2019 Oct; 18(4):445-449. PubMed ID: 31240424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study.
    Evans DG; Mason S; Huson SM; Ponder M; Harding AE; Strachan T
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):361-6. PubMed ID: 9120449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
    Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
    Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
    [No Abstract]   [Full Text] [Related]  

  • 34. FNA of epithelioid sarcoma: Curie Institute experience and critical review of the literature.
    Gajdzis P; Laé M; Klijanienko J
    Cancer Cytopathol; 2018 Nov; 126(11):934-941. PubMed ID: 30291790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
    Hadfield KD; Newman WG; Bowers NL; Wallace A; Bolger C; Colley A; McCann E; Trump D; Prescott T; Evans DG
    J Med Genet; 2008 Jun; 45(6):332-9. PubMed ID: 18285426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
    Le Loarer F; Zhang L; Fletcher CD; Ribeiro A; Singer S; Italiano A; Neuville A; Houlier A; Chibon F; Coindre JM; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jun; 53(6):475-86. PubMed ID: 24585572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.
    Vitte J; Gao F; Coppola G; Judkins AR; Giovannini M
    Nat Commun; 2017 Aug; 8(1):300. PubMed ID: 28824165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [108th French Congress of Surgery, Paris 2-4 October, 2006. Primary retroperitoneal sarcoma].
    Bonvalot S; Rivoire M
    J Chir (Paris); 2007; 144 Spec No 1():1S7-14. PubMed ID: 18044035
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma.
    Glass C; Sholl LM; Landgraf JR; Chirieac L; Roggli VL
    Am J Surg Pathol; 2020 Feb; 44(2):288-292. PubMed ID: 31567203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of cytopathologic features of epithelioid sarcoma in a series of 7 uncommon cases with immunohistochemical results, including loss of INI1/SMARCB1 in two test cases.
    Rekhi B; Singh N
    Diagn Cytopathol; 2016 Jul; 44(7):636-42. PubMed ID: 27145123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.